Literature DB >> 22993614

Relation between proinflammatory mediators and epithelial-mesenchymal transition in head and neck squamous cell carcinoma.

Geun-Woo Dong1, Nam-Yong DO, Sung-Chul Lim.   

Abstract

Increasing evidence suggests that the tumor microenvironment plays an important role in tumor progression and oncogenesis. Various proinflammatory mediators contribute to tumor proliferation, neoangiogenesis, invasion, metastasis, and resistance to cancer therapy such as hormonal therapy and chemotherapy. The major causes of death related to head and neck squamous cell carcinoma (HNSCC) include cervical node and distant metastases. Epithelial-mesenchymal transition (EMT) has been identified to play a key role in mediating the tumor invasion and metastasis of carcinomas. Herein, the relationship between proinflammatory mediators and EMT in HNSCC was investigated. Immunohistochemical expression of interleukin-1 β (IL-1β), cyclooxygenase-2 (COX-2), Slug and E-cadherin in relationship to histologic differentiation, clinical stage and nodal status was evaluated in 146 surgical specimens of HNSCC. A correlation was noted between increased expression of IL-1β and nodal status, as well as increased expression of COX-2 and histologic differentiation, clinical stage and nodal status. Increased Slug expression was correlated with histologic differentiation and clinical stage. Decreased E-cadherin expression was correlated with histologic differentiation and nodal status. A significant relationship was observed between IL-1β and COX-2. However, a significant inverse correlation was noted between Slug and E-cadherin. A significant relationship was observed between increased proinflammatory mediator IL-1β/COX-2 expression and increased EMT marker Slug/E-cadherin expression. These results indicate that proinflammatory mediators IL-1β and COX-2 may induce EMT through an increase in Slug and a decrease in E-cadherin. The present findings suggest that various anti-inflammatory agents could be used as an adjuvant treatment modality with anti-cancer chemotherapeutic drugs in HNSCC.

Entities:  

Year:  2010        PMID: 22993614      PMCID: PMC3445903          DOI: 10.3892/etm.2010.124

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  42 in total

Review 1.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

2.  The SLUG zinc-finger protein represses E-cadherin in breast cancer.

Authors:  Karen M Hajra; David Y-S Chen; Eric R Fearon
Journal:  Cancer Res       Date:  2002-03-15       Impact factor: 12.701

3.  High Twist expression is involved in infiltrative endometrial cancer and affects patient survival.

Authors:  Satoru Kyo; Junko Sakaguchi; Satoshi Ohno; Yasunari Mizumoto; Yoshiko Maida; Manabu Hashimoto; Mitsuhiro Nakamura; Masahiro Takakura; Miki Nakajima; Kenkichi Masutomi; Masaki Inoue
Journal:  Hum Pathol       Date:  2006-04       Impact factor: 3.466

Review 4.  Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways.

Authors:  Lionel Larue; Alfonso Bellacosa
Journal:  Oncogene       Date:  2005-11-14       Impact factor: 9.867

5.  Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines.

Authors:  Caren C Bancroft; Zhong Chen; Jason Yeh; John B Sunwoo; Ning T Yeh; Sadhana Jackson; Chad Jackson; Carter Van Waes
Journal:  Int J Cancer       Date:  2002-06-01       Impact factor: 7.396

6.  Slug Expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma.

Authors:  Yasuto Uchikado; Shoji Natsugoe; Hiroshi Okumura; Tetsuro Setoyama; Masataka Matsumoto; Sumiya Ishigami; Takashi Aikou
Journal:  Clin Cancer Res       Date:  2005-02-01       Impact factor: 12.531

Review 7.  Inflammation: a driving force speeds cancer metastasis.

Authors:  Yadi Wu; Binhua P Zhou
Journal:  Cell Cycle       Date:  2009-10-03       Impact factor: 4.534

8.  E-cadherin: a differentiation marker in thyroid malignancies.

Authors:  G Brabant; C Hoang-Vu; Y Cetin; H Dralle; G Scheumann; J Mölne; G Hansson; S Jansson; L E Ericson; M Nilsson
Journal:  Cancer Res       Date:  1993-10-15       Impact factor: 12.701

9.  E-cadherin loss rather than beta-catenin alterations is a common feature of poorly differentiated thyroid carcinomas.

Authors:  A S Rocha; P Soares; E Fonseca; J Cameselle-Teijeiro; M C Oliveira; M Sobrinho-Simões
Journal:  Histopathology       Date:  2003-06       Impact factor: 5.087

Review 10.  A novel mechanism for inflammation-associated carcinogenesis; an important role of activation-induced cytidine deaminase (AID) in mutation induction.

Authors:  Tsutomu Chiba; Hiroyuki Marusawa
Journal:  J Mol Med (Berl)       Date:  2009-10       Impact factor: 4.599

View more
  5 in total

1.  Pre-treatment circulating neutrophil count is an independent prognostic factor in oropharyngeal cancer.

Authors:  Liang Li; Guangping Liu; Honglue Lu; Kai Jin; Xiang Zhai; Mengqian Zhou; Yuansheng Duan; Kai Yue; Yansheng Wu; Xudong Wang
Journal:  Ann Transl Med       Date:  2020-09

2.  Identification of pyroptosis-related signature for cervical cancer predicting prognosis.

Authors:  Cankun Zhou; Chaomei Li; Yuhua Zheng; Xiaochun Liu
Journal:  Aging (Albany NY)       Date:  2021-11-27       Impact factor: 5.682

3.  Modulation of IL-1β reprogrammes the tumor microenvironment to interrupt oral carcinogenesis.

Authors:  Tong Wu; Yun Hong; Lihua Jia; Jie Wu; Juan Xia; Juan Wang; Qinchao Hu; Bin Cheng
Journal:  Sci Rep       Date:  2016-02-01       Impact factor: 4.379

4.  Prognosis Value of Platelet Counts, Albumin and Neutrophil-Lymphocyte Ratio of Locoregional Recurrence in Patients with Operable Head and Neck Squamous Cell Carcinoma.

Authors:  Jing Ye; Bing Liao; Xiaohua Jiang; Zhihuai Dong; Sunhong Hu; Yuehui Liu; Mang Xiao
Journal:  Cancer Manag Res       Date:  2020-01-31       Impact factor: 3.989

Review 5.  IL-1/IL-1R Signaling in Head and Neck Cancer.

Authors:  Sven E Niklander; Craig Murdoch; Keith D Hunter
Journal:  Front Oral Health       Date:  2021-08-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.